Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort

  • Marinda Meertens
  • , Eline L. Giraud
  • , the Dutch Pharmacology Oncology Group (DPOG)
  • , Maud B.A. van der Kleij
  • , Kim Westerdijk
  • , Niels A.D. Guchelaar
  • , Roos F. Bleckman
  • , Amy Rieborn
  • , Alex L.T. Imholz
  • , Hans Martin Otten
  • , Annelie Vulink
  • , Maartje Los
  • , Paul Hamberg
  • , Winette T.A. van der Graaf
  • , Hans Gelderblom
  • , Dirk Jan A.R. Moes
  • , K. Esther Broekman
  • , Daan J. Touw
  • , Stijn L.W. Koolen
  • , Ron H.J. Mathijssen
    • Alwin D.R. Huitema, Nielka P. van Erp, Ingrid M.E. Desar, Neeltje Steeghs*
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)
20 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science